Literature DB >> 15073173

14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain.

Zongfei Yuan1, Alka Agarwal-Mawal, Hemant K Paudel.   

Abstract

In mammalian brain, tau, glycogen synthase kinase 3beta (GSK3beta), and 14-3-3, a phosphoserine-binding protein, are parts of a multiprotein tau phosphorylation complex. Within the complex, 14-3-3 simultaneously binds to tau and GSK3beta (Agarwal-Mawal, A., Qureshi, H. Y., Cafferty, P. W., Yuan, Z., Han, D., Lin, R., and Paudel, H. K. (2003) J. Biol. Chem. 278, 12722-12728). The molecular mechanism by which 14-3-3 connects GSK3beta to tau within the complex is not clear. In this study, we find that GSK3beta within the tau phosphorylation complex is phosphorylated on Ser(9). From extracts of rat brain and rat primary cultured neurons, Ser(9)-phosphorylated GSK3beta precipitates with glutathione-agarose beads coated with glutathione S-transferase-14-3-3. Similarly, from rat brain extract, Ser(9)-phosphorylated GSK3beta co-immunoprecipitates with tau. In vitro, 14-3-3 binds to GSK3beta only when the kinase is phosphorylated on Ser(9). In transfected HEK-293 cells, 14-3-3 binds to Ser(9)-phosphorylated GSK3beta and does not bind to GSK3beta (S9A). Tau, on the other hand, binds to both GSK3beta (WT) and GSK3beta (S9A). Moreover, 14-3-3 enhances the binding of tau with Ser(9)-phosphorylated GSK3beta by approximately 3-fold but not with GSK3beta (S9A). Similarly, 14-3-3 stimulates phosphorylation of tau by Ser(9)-phosphorylated GSK3beta but not by GSK3beta (S9A). In transfected HEK-293 cells, Ser(9) phosphorylation suppresses GSK3beta-catalyzed tau phosphorylation in the absence of 14-3-3. In the presence of 14-3-3, however, Ser(9)-phosphorylated GSK3beta remains active and phosphorylates tau. Our data indicate that within the tau phosphorylation complex, 14-3-3 connects Ser(9)-phosphorylated GSK3beta to tau and Ser(9)-phosphorylated GSK3beta phosphorylates tau.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073173     DOI: 10.1074/jbc.M308298200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding.

Authors:  Mónica Alvarez; Xavier Altafaj; Sergi Aranda; Susana de la Luna
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  Proteomic analysis of bovine sperm YWHA binding partners identify proteins involved in signaling and metabolism.

Authors:  Pawan Puri; Kimberley Myers; Douglas Kline; Srinivasan Vijayaraghavan
Journal:  Biol Reprod       Date:  2008-08-27       Impact factor: 4.285

Review 5.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.

Authors:  Eleonore Beurel; Steven F Grieco; Richard S Jope
Journal:  Pharmacol Ther       Date:  2014-11-27       Impact factor: 12.310

6.  Loss of Hsp110 leads to age-dependent tau hyperphosphorylation and early accumulation of insoluble amyloid beta.

Authors:  Binnur Eroglu; Demetrius Moskophidis; Nahid F Mivechi
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

7.  14-3-3 and β-catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway.

Authors:  Shiri Dovrat; Michal Caspi; Alona Zilberberg; Lital Lahav; Anastasia Firsow; Hila Gur; Rina Rosin-Arbesfeld
Journal:  Mol Oncol       Date:  2014-03-22       Impact factor: 6.603

8.  Downregulation of 14-3-3 Proteins in Alzheimer's Disease.

Authors:  Qiang Gu; Elvis Cuevas; James Raymick; Jyotshna Kanungo; Sumit Sarkar
Journal:  Mol Neurobiol       Date:  2019-09-05       Impact factor: 5.590

9.  Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease.

Authors:  Jesper Riise; Niels Plath; Bente Pakkenberg; Anna Parachikova
Journal:  J Neural Transm (Vienna)       Date:  2015-02-14       Impact factor: 3.575

10.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.